Longmen Pharmaceutical's half -annual net profit of 5.614 million yuan in 2022 increased by 18.96% year -on -year

On July 25, Longmen Pharmaceutical (Code: 873356.NQ) released the performance report of the 2022 half -year report.

From January 1, 2022-June 30, 2022, the company realized operating income of 18.7025 million yuan, an increase of 13.71%year-on-year, and net profit was 5.6114 million yuan, an increase of 18.96%year-on-year, and the basic earnings per share were 0.2800 yuan.

The company's industry is chemical pharmaceutical.

During the company's reporting period, the total assets at the end of the period were 59.381 million yuan, the operating profit was 6.7353 million yuan, the accounts receivable were 2.86 million yuan, and the net cash flow generated by operating activities was 7.9489 million yuan.Cash is 170.481 million yuan.

Longmen Pharmaceutical, the company's full name Luoyang Longmen Pharmaceutical Co., Ltd., was established on September 18, 1996. The current general manager Yang Hongtao.Sales.

- END -